MCM
CELG

Marathon Capital Management’s Celgene Corp CELG Stock Holding History

Marathon Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-17,390
Closed -$1.73M – 154
2019
Q3 		$1.73M Sell
17,390
-350
-2% -$33.3K 0.7% 23
2019
Q2 		$1.64M Sell
17,740
-575
-3% -$54.6K 0.67% 26
2019
Q1 		$1.73M Sell
18,315
-225
-1% -$19.7K 0.77% 25
2018
Q4 		$1.19M Sell
18,540
-1,365
-7% -$101K 0.59% 31
2018
Q3 		$1.78M Sell
19,905
-525
-3% -$46.4K 0.69% 29
2018
Q2 		$1.62M Sell
20,430
-995
-5% -$82.6K 0.61% 35
2018
Q1 		$1.91M Buy
21,425
+130
+0.6% +$12.5K 0.75% 26
2017
Q4 		$2.22M Buy
21,295
+4,195
+25% +$473K 0.87% 20
2017
Q3 		$2.49M Sell
17,100
-350
-2% -$47.7K 1.05% 18
2017
Q2 		$2.27M Buy
17,450
+1,075
+7% +$132K 1.07% 16
2017
Q1 		$2.04M Sell
16,375
-25
-0.2% -$2.99K 1.01% 20
2016
Q4 		$1.9M Buy
16,400
+2,300
+16% +$256K 0.9% 17
2016
Q3 		$1.47M Buy
+14,100
New +$1.53M 0.73% 28

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Marathon Capital Management's CELG Position: Q4 2019 in Review

Marathon Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 17,390 shares — an estimated $1.73M sold.

Marathon Capital Management first reported a position in CELG in Q3 2016 and held it in 13 quarters. The position peaked at $2.49M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Marathon Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Marathon Capital Management sold 17,390 Celgene Corp shares in Q4 2019, an estimated $1.73M.
  • Marathon Capital Management first reported a position in Celgene Corp in Q3 2016 and held it in 13 quarters.
  • Marathon Capital Management's Celgene Corp position peaked at $2.49M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Marathon Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.